Adicet Financial Statements From 2010 to 2025
| ACET Stock | USD 0.59 0.02 3.28% |
Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
Check out the analysis of Adicet Bio Correlation against competitors. Adicet Bio Company Shares Owned By Insiders Analysis
Adicet Bio's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Adicet Bio Shares Owned By Insiders | 2.74 % |
Most of Adicet Bio's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adicet Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.736% of Adicet Bio are shares owned by insiders. This is 81.98% lower than that of the Health Care Providers & Services sector and 80.71% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 72.88% higher than that of the company.
Adicet Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adicet Bio's current stock value. Our valuation model uses many indicators to compare Adicet Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adicet Bio competition to find correlations between indicators driving Adicet Bio's intrinsic value. More Info.Adicet Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Adicet Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Adicet Bio Financial Statements
Adicet Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.